$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
卡博替尼可明显延长甲状腺髓样癌患者总生存期
2025-10-19 11:44:20
Check Details
卡博替尼治疗晚期甲状腺髓样癌的疗效分析
2025-10-19 11:44:20
Check Details
多靶点抗癌药卡博替尼在中国纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
卡博替尼治疗转移性甲状腺髓样癌的效果数据
2025-10-19 11:44:20
Check Details
晚期甲状腺髓样癌治疗选择-卡博替尼
2025-10-19 11:44:20
Check Details
RET突变甲状腺髓样癌患者治疗希望-塞尔帕替尼
2025-10-19 11:44:20
Check Details
塞尔帕替尼(Retevmo)对晚期RET融合阳性甲状腺癌患者的疗效
2025-10-19 11:44:20
Check Details
塞尔帕替尼(Retevmo)国内哪里能买到?多少钱一盒?
2025-10-19 11:44:20
Check Details
仑伐替尼治疗局部放射性碘难治性分化型甲状腺癌疗效如何?2分钟即可了解
2025-10-19 11:44:20
Check Details
如何正确应对甲状腺癌患者服用仑伐替尼的副作用?
2025-10-19 11:44:20
Check Details
塞尔帕替尼治疗RET突变型甲状腺髓样癌的疗效和安全性
2025-10-19 11:44:20
Check Details
【正确服药】仑伐替尼在甲状腺癌中最正确的用法用量是多少?
2025-10-19 11:44:20
Check Details
1
2
...
8579
8580
8581
8582
8583
8584
8585
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
2
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
3
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
4
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
5
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
6
Avatrombopag (Doptelet) Dosage: Dose Adjustment and Medication Guidelines for Different Indications
7
Effects of Gilteritinib (Xospata) Discontinuation in Acute Myeloid Leukemia Treatment
8
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
9
Deucravacitinib (Sotyktu): TYK2 Inhibitor Guide for Plaque Psoriasis Treatment
10
Biktarvy (Bictegravir/Emtricitabine/TAF) Dosing & Food Administration Guide
11
Valganciclovir (Valcyte) CMV Infection: Dosing Duration & Management Guide
12
Cabergoline Dosing Guide: Hyperprolactinemia & Prolactin Level Regulation